A recent study showed tumor-infiltrating CD8+ T cells in breast tumors’ microenvironment were associated with the effect of anti-BRCA immune response, better patient survival, and anti-metastatic progression [29]. The gene discussed is CD8A; the disease is breast neoplasm.